US Patent Issued to Xencor on July 15 for "Heterodimeric antibodies that bind CD3 and tumor antigens" (California Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,359,002, issued on July 15, was assigned to Xencor Inc. (Pasadena, Calif.).

"Heterodimeric antibodies that bind CD3 and tumor antigens" was invented by Matthew Bernett (Monrovia, Calif.), Gregory Moore (Azusa, Calif.), John Desjarlais (Pasadena, Calif.), Seung Chu (Cypress, Calif.), Rumana Rashid (Temple City, Calif.), Umesh Muchhal (Monrovia, Calif.) and Sung-Hyung Lee (San Gabriel, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to novel heterodimeric antibodies."

The patent was filed on April 27, 2023, under Application No. 18/308,623.

*For further information, including images, charts and tables, please visi...